Table 1 Risk analysis for the expression of miR-23b in cervical tissues
From: miR-23b as a potential tumor suppressor and its regulation by DNA methylation in cervical cancer
Expression of miR-23b | Clinical diagnosis | OR (95 % CI) | Value of p | |
|---|---|---|---|---|
SILs (n = 26) | Cervical Cancer (n = 28) | |||
Low level | 2 (7.7 %) | 21 (75 %) | 36 (6.7-192.6) | <0.05 |
High level | 24 (92.3 %) | 7 (25 %) | 1.0* | |